Form 4: Hims & Hers Director Granted RSUs

Hims & Hers Health, Inc. Director Delos M. Cosgrove was granted 3,656 Restricted Stock Units, vesting by mid-2026.

Summary

• Director Delos M. Cosgrove of Hims & Hers Health, Inc. received a grant of 3,656 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of Class A Common Stock.
• The RSUs will vest on the earlier of the 2026 annual meeting of stockholders or June 15, 2026, subject to continuous service.
• The grant date for this transaction was August 6, 2025.

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to a director is a positive development as it aligns the director's long-term interests with shareholder value and is a standard practice for executive compensation.

Positives

• The grant of Restricted Stock Units aligns the director's interests with long-term shareholder value.
• RSU grants are a common form of equity compensation for directors, indicating continued commitment to the company.

Risks

• The Restricted Stock Units are subject to continuous service, meaning the director must remain with the company until the vesting date to receive the shares.

Future Outlook

The grant of Restricted Stock Units to a director signifies a future increase in their direct equity ownership in the company, aligning their long-term interests with shareholder value.

Industry Context

The grant of Restricted Stock Units to a director is a common practice in the industry for executive and director compensation, aiming to align their incentives with the long-term performance of the company and shareholder interests.

Comparison to Industry Standards

• The grant of Restricted Stock Units is a standard form of equity compensation for directors across publicly traded companies, comparable to practices at other growth-oriented healthcare technology firms.

Related Party Transactions

• The grant of Restricted Stock Units to a director constitutes a related party transaction, which is a standard form of compensation for board members.

Stakeholder Impact

• Shareholders: Aligns the director's interests with long-term shareholder value.

Next Steps

• The granted Restricted Stock Units are scheduled to vest on the earlier of the 2026 annual meeting of stockholders or June 15, 2026.

Key Dates

Recommendation

The filing reports a routine grant of Restricted Stock Units to a director, which is a standard form of equity compensation. This action aligns the director's interests with long-term shareholder value but does not provide new fundamental information that would warrant a change in investment recommendation.

Keywords

Hims & Hers, HIMS, Director, Restricted Stock Units, RSU, Equity Compensation, Insider Transaction, SEC Form 4